EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Distinguishing hypertensive cardiomyopathy from cardiac amyloidosis in hypertensive patients with heart failure: a CMR study with histological confirmation

Katarzyna Elzbieta Gil, Vien Truong, Chuanfen Liu, Dalia Y Ibrahim, Katarzyna Mikrut, Anjali Satoskar, Juliet Varghese, Rami Kahwash, Yuchi Han

The International Journal of Cardiovascular Imaging · 17.10.2024 · 40 (12) · 2559-2570

DOI: 10.1007/s10554-024-03262-0 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The International Journal of Cardiovascular Imaging, online erschienen am 17.10.2024. Verfasst von Katarzyna Elzbieta Gil und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, 452 W 10th Ave Columbus, Columbus, OH, 43210, USA. katarzyna.gi…. Hauptthemen laut MEDLINE: Predictive Value of Tests, Cardiomyopathies, Magnetic Resonance Imaging, Cine, Heart Failure. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Differentiation of the cause of left ventricular hypertrophy (LVH) is challenging in cases with co-existing hypertension. CMR offers assessment of diffuse myocardial abnormalities via T1 mapping with extracellular volume fraction (ECV) and macroscopic fibrosis via late gadolinium enhancement imaging (LGE). The goal of the study was to understand if CMR parameters can differentiate hypertensive cardiomyopathy (HC) from cardiac amyloidosis (CA) in patients with hypertension and heart failure, using endomyocardial biopsy (EMB) as the gold standard.

Methods

We retrospectively analyzed patients with hypertension, LVH, and heart failure undergoing EMB due to uncertain diagnosis. CMR parameters including cine, LGE characteristics, T1 mapping, and ECV were analyzed.

Results

A total of 34 patients were included (mean age 66.5 ± 10.7 years, 79.4% male). The final EMB-based diagnosis was HC (10, 29%), light chain (AL) CA (7, 21%), and transthyretin (ATTR) CA (17, 50%). There was a significant difference in subendocardial LGE ( p = 0.03) and number of AHA segments with subendocardial LGE ( p = 0.005). The subendocardial LGE pattern was most common in AL-CA (85.7%) and African American with HC (80%). ECV elevation (≥ 29%) was present in all patients with CA (AL-CA: 57.6 ± 5.2%, ATTR-CA: 59.1 ± 15.3%) and HC (37.3 ± 4.5%).

Conclusions

Extensive subendocardial LGE pattern is not pathognomonic for CA but might also be present in African American patients with longstanding or poorly controlled HTN. The ECV elevation in HC with HF might be more significant than previously reported with an overlap of ECV values in HC and CA, particularly in younger African American patients. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Predictive Value of TestsCardiomyopathiesMagnetic Resonance Imaging, CineHeart FailureHypertrophy, Left VentricularMyocardiumHypertensionHumansFemaleMaleAgedMiddle AgedRetrospective StudiesBiopsyDiagnosis, DifferentialVentricular Function, LeftContrast MediaAmyloidosisFibrosisAmyloid Neuropathies, FamilialReproducibility of Results

Stichwörter der Autor:innen

Cardiac amyloidosisCardiovascular magnetic resonance imagingExtracellular volume fractionHypertensive heart diseaseLate gadolinium enhancement imagingLeft ventricular hypertrophy

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, 452 W 10th Ave Columbus, Columbus, OH, 43210, USA. katarzyna.gil@osumc.edu.
  • Department of Internal Medicine, Nazareth Hospital, Philadelphia, PA, USA.
  • Department of Cardiology, Peking University People's Hospital, Beijing, China.
  • Department of Pathology, University of Toledo Medical Center, Toledo, OH, USA.
  • Advocate Heart Institute, Advocate Lutheran General Hospital, Chicago, IL, USA.
  • Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Gil, K. E., Truong, V., Liu, C., Ibrahim, D. Y., Mikrut, K., Satoskar, A., Varghese, J., Kahwash, R., & Han, Y. (2024). Distinguishing hypertensive cardiomyopathy from cardiac amyloidosis in hypertensive patients with heart failure: a CMR study with histological confirmation. The International Journal of Cardiovascular Imaging, 40(12), 2559-2570. https://doi.org/10.1007/s10554-024-03262-0

Vancouver

Gil KE, Truong V, Liu C, Ibrahim DY, Mikrut K, Satoskar A, et al. Distinguishing hypertensive cardiomyopathy from cardiac amyloidosis in hypertensive patients with heart failure: a CMR study with histological confirmation. The International Journal of Cardiovascular Imaging. 2024;40(12):2559-2570. doi:10.1007/s10554-024-03262-0

BibTeX
@article{Gil2024,
  author = {Gil, Katarzyna Elzbieta and Truong, Vien and Liu, Chuanfen and Ibrahim, Dalia Y and Mikrut, Katarzyna and Satoskar, Anjali and Varghese, Juliet and Kahwash, Rami and Han, Yuchi},
  title = {Distinguishing hypertensive cardiomyopathy from cardiac amyloidosis in hypertensive patients with heart failure: a CMR study with histological confirmation},
  journal = {The International Journal of Cardiovascular Imaging},
  year = {2024},
  volume = {40},
  number = {12},
  pages = {2559--2570},
  doi = {10.1007/s10554-024-03262-0}
}
Kostenlos starten →